REFERENCES
- World Health Organization Expanded Program of Research. Development and Research Training in Human Reproduction Task Force on Long-acting Systemic Agents for the Regulation of Fertility. Multinational comparative clinical evaluation of two long-acting injectable contraceptive steroids: norethisterone enanthate and medroxyprogesterone acetate. Final report. Contraception 1983; 28: 1
- Weisberg E. The Depo-Provera controversy: regulatory, medical and social issues. Depo-Provera for Contraception, D Zambrano. Oxford Clinical Communications, Oxford 1993; 27–36
- Paul C, Skegg D C, Williams S. Depo medroxy-progesterone acetate. Patterns of use and reasons for discontinuation. Contraception 1997; 56: 209–14
- Polaneczky M, Guarnaccia M, Alon J, et al. Early experience with the contraceptive use of Depo medroxy-progesterone acetate in an inner-city clinic population. Fam Plann Perspect 1996; 28: 174–8
- Kaunitz A M. Clinical use of Depo-Provera for contraception. Depo-Provera for Contraception, D Zambrano. Oxford Clinical Communications, Oxford 1993; 39–49